Simplex Trading’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.8K Sell
1,351
-7,791
-85% -$192K ﹤0.01% 6065
2025
Q4
$191K Buy
9,142
+8,374
+1,090% +$156K ﹤0.01% 4282
2025
Q3
$12K Buy
+768
New +$15.8K ﹤0.01% 7787
2023
Q2
Sell
-60
Closed -$678 10131
2023
Q1
$0 Buy
+60
New +$835 ﹤0.01% 10323
2022
Q3
Sell
-21
Closed 11059
2022
Q2
$0 Sell
21
-158
-88% -$1.86K ﹤0.01% 11310
2022
Q1
$2K Buy
+179
New +$3.7K ﹤0.01% 9967
2021
Q2
Sell
-476
Closed -$56.4K 10831
2021
Q1
$72K Buy
476
+425
+833% +$69.1K ﹤0.01% 6180
2020
Q4
$8K Buy
51
+6
+13% +$1.07K ﹤0.01% 7550
2020
Q3
$7K Buy
+45
New +$9.07K ﹤0.01% 6982

Other funds holding TECX

Simplex Trading's TECX Position: Q1 2026 in Review

Simplex Trading reduced its Tectonic Therapeutic (TECX) stake by 85% in Q1 2026, selling an estimated $192K and leaving 1,351 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6065.

Simplex Trading first reported a position in TECX in Q3 2020 and has held it in 9 quarters since. The position peaked at $191K in Q4 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Simplex Trading held 1,351 shares of Tectonic Therapeutic worth $41.8K as of Q1 2026.
  • Simplex Trading sold 7,791 Tectonic Therapeutic shares in Q1 2026, an estimated $192K.
  • Tectonic Therapeutic made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6065 holding.
  • Simplex Trading first reported a position in Tectonic Therapeutic in Q3 2020 and has held it in 9 quarters since.
  • Simplex Trading's Tectonic Therapeutic position peaked at $191K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.